Microbial profile of donor lungs: data from 2009 to 2016

P. Leon Bueno De Camargo (Sao Paulo/Sp, Brazil)

Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Session: From donor lung selection and organ preservation to lung transplant outcome
Session type: Poster Discussion
Number: 1544
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Leon Bueno De Camargo (Sao Paulo/Sp, Brazil). Microbial profile of donor lungs: data from 2009 to 2016. 1544

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung transplantation in Portugal: 2008-2010 results
Source: Annual Congress 2011 - Lung transplantation
Year: 2011

Italian registry of lung transplantation: data since1988 to 2000
Source: Eur Respir J 2002; 20: Suppl. 38, 563s
Year: 2002

Changes in asthma drug use in France between 2006 and 2015: a claims data study
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018


Evaluation of a lung donor score: retrospective analysis of Swiss donor data
Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Year: 2017

The second national survey of Italian respiratory high dependency units: changes from 1996 to 2006
Source: Annual Congress 2008 - Noninvasive mechanical ventilation in the acute setting
Year: 2008


Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study
Source: Eur Respir J 2015; 46: 1131-1139
Year: 2015



Changes in smoking and lung function between 2001 and 2016. The Tromsø Study.
Source: International Congress 2019 – More and more COPD
Year: 2019


Survival at low lung function in cystic fibrosis: Cohort study from 1995 to 2010
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012

Tuberculosis incidence in Sardinia (Italy) in the adult population, in the last 8 years (2002-2009): Increase, decrease or stabilization? Preliminary data
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010

Increasing difference in survival between women and men from 2001 to 2010: Data from the Danish oxygen register
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


CARESS: The Canadian registry of palivizumab (2005-2010)
Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae
Year: 2011


“Protect your lungs: get vaccinated.” Breathe 2019; 15: 263–264.
Source: Breathe, 15 (4) 358; 10.1183/20734735.ELF553
Year: 2019


Comparative analysis of lung cancer presentation between 1990 and 2003
Source: Eur Respir J 2005; 26: Suppl. 49, 321s
Year: 2005

Comparison of two respiratory surveys in an unselected schoolchildren population: 1998 and 2011
Source: Annual Congress 2012 - Paediatric respiratory epidemiology. Wheeze: where, how and why?
Year: 2012


Time trends in asthma: Changes of prevalence from 1990 to 2010 in Italy. Preliminary results from the screening stage of the Genes Environment Interaction in Respiratory Diseases (GEIRD) study
Source: Annual Congress 2010 - Highlights of longitudinal, geographical and time trend studies of asthma and COPD
Year: 2010

Risk factors that determine time to first RSV hospitalization in CARESS: The Canadian registry of palivizumab (2005-2011)
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012

Late Breaking Abstract: Results of the first year of the "population-based nationwide surveillance of invasive pneumococcal disease (IPD) among adults >50 years old in Belgium" (2009-2010)
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010

Analysis of the deaths among tuberculosis patients in Iasi area throughout seven years (from 1998 to 2005)
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007


Real-world effects of lumacaftor/ivacaftor (LUM/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021